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Occurrence and Genetic Characteristics
of Third-Generation Cephalosporin-Resistant
Escherichia coli in Swiss Retail Meat
Debora Vogt,1 Gudrun Overesch,1 Andrea Endimiani,2 Alexandra Collaud,1
Andreas Thomann,1 and Vincent Perreten1
Prevalence and genetic relatedness were determined for third-generation cephalosporin-resistant Escherichia coli
(3GC-R-Ec) detected in Swiss beef, veal, pork, and poultry retail meat. Samples from meat-packing plants
(MPPs) processing 70% of the slaughtered animals in Switzerland were purchased at different intervals between
April and June 2013 and analyzed. Sixty-nine 3GC-R-Ec isolates were obtained and characterized by microarray,
PCR/DNA sequencing, Multi Locus Sequence Typing (MLST), and plasmid replicon typing. Plasmids of selected
strains were transformed by electroporation into E. coli TOP10 cells and analyzed by plasmid MLST. The
prevalence of 3GC-R-Ec was 73.3% in chicken and 2% in beef meat. No 3GC-R-Ec were found in pork and veal.
Overall, the blaCTX-M-1 (79.4%), blaCMY-2 (17.6%), blaCMY-4 (1.5%), and blaSHV-12 (1.5%) b-lactamase genes
were detected, as well as other genes conferring resistance to chloramphenicol (cmlA1-like), sulfonamides (sul),
tetracycline (tet), and trimethoprim (dfrA). The 3GC-R-Ec from chicken meat often harbored virulence genes
associated with avian pathogens. Plasmid incompatibility (Inc) groups IncI1, IncFIB, IncFII, and IncB/O were the
most frequent. A high rate of clonality (e.g., ST1304, ST38, and ST93) among isolates from the same MPPs
suggests that strains persist at the plant and spread to meat at the carcass-processing stage. Additionally, the
presence of the blaCTX-M-1 gene on an IncI1 plasmid sequence type 3 (IncI1/pST3) in genetically diverse strains
indicates interstrain spread of an epidemic plasmid. The blaCMY-2 and blaCMY-4 genes were located on IncB/O
plasmids. This study represents the first comprehensive assessment of 3GC-R-Ec in meat in Switzerland. It
demonstrates the need for monitoring contaminants and for the adaptation of the Hazard Analysis and Critical
Control Point concept to avoid the spread of multidrug-resistant bacteria through the food chain.
Introduction
S ince the introduction of third-generation cephalo-sporins, a large number of extended-spectrum b-lactamase
(ESBL), chromosomally mediated, and plasmid-mediated
AmpC b-lactamase (cAmpC and pAmpC) producers have
emerged in Gram-negative bacteria, particularly in En-
terobacteriaceae such as Escherichia coli.14,49 ESBL enzymes
belong to Ambler class A and are mainly represented by the
SHV-, TEM-, and CTX-M-type families. The latter is the
most frequent, with*150 different types categorized into
five groups.45,53 ESBLs hydrolyze penicillins, first- to fourth-
generation cephalosporins and monobactams, but they are in-
hibited by the standard b-lactamase inhibitors (e.g., clavulanate
and tazobactam). Plasmid-mediatedAmpCb-lactamases belong
to Ambler class C, hydrolyze penicillins and all cephalosporins
(with the exception of the fourth-generation, e.g., cefepime), and
are not inhibited byb-lactamase inhibitors. They are divided into
six clusters, the most common being the CMY family.32
E. coli is a normal inhabitant of the gut of humans and
animals; however, certain E. coli have acquired different vir-
ulence factors causing host-specific infections. Extraintestinal
pathogenic E. coli (ExPEC) are responsible for colibacillosis in
various animal species, including poultry (avian pathogenic E.
coli [APEC]),19 urinary tract infections (uropathogenic E. coli),
and newborn meningitis (newborn meningitis-causing E.
coli).23 Enterotoxigenic E. coli can cause diarrhea in calves,27
pigs,24 and humans. Enterohemorrhagic E. coli (EHEC) can be
commensal or pathogenic in cattle and have been of great
interest as meat and vegetable contaminants, as they cause
severe illness in humans.42,55 E. coli are also responsible for
wound infections, pneumonia, and septicemia in people.14,25,49
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The emergence of third-generation cephalosporin-resistant
E. coli (3GC-R-Ec) isolates is associated with prolonged hos-
pitalization, higher health costs, and mortality.41 In addition,
3GC-R-Ec can carry other antibiotic resistances, such as those
against aminoglycosides, chloramphenicol, trimethoprim, tet-
racycline, sulfonamides, and quinolones. These genes are fre-
quently located on the same genetic elements (e.g., plasmids,
integrons) as the blaESBL and blapAmpC genes. It has been
shown that these genetic elements can be transferred from
commensals to pathogens and vice versa.41,49 This phenome-
non was well demonstrated by Leverstein-van Hall et al., who
found that in 19% of isolates from human patients, the plas-
mids containing the blaESBL were indistinguishable from those
isolated from poultry meat.39,49
Therefore, treating 3GC-R-Ec infections is becoming a
challenge for clinicians and a growing concern for human
health. Furthermore, the use of carbapenems to treat 3GC-R
bacteria favors the selection of carbapenemase producers,
which are able to hydrolyze carbapenems, leaving only colis-
tin, fosfomycin, and tigecycline as last therapeutic options.44,49
Since the beginning of the 21st century, ESBL- and
pAmpC-producing isolates have been increasingly reported
in livestock such as broilers, cattle, and pigs, but data about
3GC-R-Ec in meat are still scarce.5,22,49 This situation raised
public health and food safety concerns about whether food-
producing animals act as reservoirs for 3GC-R-Ec, which
may contaminate meat and thus reach consumers, where
3GC-R-Ec could transfer genetic elements to human path-
ogenic E. coli.16,37,40,49
In Switzerland, preliminary studies indicated a high
prevalence of 3GC-R-Enterobacteriaceae in both indige-
nous and imported poultry meat.1,50 Another study recently
showed a high rate of contamination of chicken meat re-
ceived at a Swiss hospital kitchen.52 The aim of this study
was to determine a more general and representative preva-
lence of 3GC-R-Ec in different lots of Swiss beef, pork,
poultry, and veal retail meat and to determine their molec-
ular characteristics. This study represents the first national
surveillance of 3GC-R-Ec in meat, using a sampling plan
based on representative production data from Swiss meat
processing plants, and could therefore also serve as a basis
for national monitoring of antibiotic resistance in fresh meat
products at retail in Switzerland.
Materials and Methods
Sampling
Meat from meat-packing plants (MPPs) processing at least
70% of the slaughtered animals in Switzerland was analyzed
in a time frame spanning fromMarch 2013 to June 2013. This
set encompasses a total of seven different MPPs, including
two MPPs (MPPA and MPPB) processing solely poultry
meat, four MPPs (MPPC1, MPPD, MPPE1, and MPPF1)
processing beef, three MPPs (MPPC2, MPPE2, and MPPF2)
processing pork, and three MPPs (MPPC3, MPPE3, and
MPPG) processing veal. One type of meat among chicken
breast, pork, beef, and veal escalope was analyzed every 4
weeks to avoid sampling the same batch twice. Twenty-five
chicken meat samples selected in different stores selling
products from MPPA (n= 37) and MPPB (n= 38) were pur-
chased three times at 4-week intervals for a total of 75
chicken breast samples. Twenty-five pork, beef, and veal
escalopes were purchased twice at 4-week intervals from
different stores selling meat from MPPC (n= 44), MPPD
(n= 12), MPPE (n= 54), MPPF (n= 28), and MPPG (n= 12),
for a total of 50 samples each.
Isolation and identification of 3GC-R-Ec
Twenty-five grams of meat was homogenized in 25ml of
LB broth in a stomacher (Stomacher 400 Circulator, Sew-
ard) for 1min and incubated overnight at 37C with agita-
tion. A loop full (10ml) of this overnight culture was
streaked onto MacConkey agar (Oxoid), Chrom ID ESBL
agar (bioMe´rieux), and Brilliance CRE agar (Oxoid) se-
lective plates and incubated overnight at 37C.
Lactose-positive colonies on MacConkey agar, reddish or
white colonies on Chrom ID ESBL agar, and every colony
growing on the Brilliance CRE agar plate were transferred
onto Tryptone soy agar plates containing 5% sheep blood
(TSA-SB; Becton Dickinson) and incubated overnight at
37C. The colonies were identified using a matrix-assisted
laser desorption/ionization time-of-flight mass spectrometer
(MALDI-TOF MS, microflex LT; Bruker Daltonics). Iso-
lates growing on Brilliance CRE agar plates were further
tested by ertapenem (Becton Dickinson) disk diffusion tests
according to the Clinical and Laboratory Standards Institute
(CLSI) guidelines 2013.11
Antimicrobial susceptibility testing
Minimum inhibitory concentrations (MIC) were obtained
by broth microdilution in cation adjusted Mueller-Hinton
using ESB1F and EUMVS2 Sensititre plates (TREK Di-
agnostic Systems). Interpretations of MIC were performed
according to the CLSI guidelines.11
Detection of antibiotic resistance
and virulence factor genes
DNA was obtained by incubating half a loop full of
bacteria in 400ml of lysis buffer (0.1M Tris-HCl pH 8.5,
0.05% Tween 20 and 0.24mg/ml proteinase K) for 45min at
60C followed by 15min at 95C.
Antibiotic resistance and virulence factor genes were de-
tected using AMR08 ArrayStripmicroarrays (an upgrade of
Card et al. 20139) and the HybridisationPlus(+ ) Kit (Alere
Technologies GmbH). A signal intensity of 0.4 or higher was
considered positive. The presence of b-lactam resistance
genes blaSHV and blaTEM, and virulence factor genes was
confirmed by PCR and sequencing with already published
primers.26,31,38,43,51 New primers were designed with the
NCBI primer-Blast tool (www.ncbi.nlm.nih.gov/tools/primer-
blast): For the amplification and sequencing of the entire
CTX-M Group 1 genes: CTX-M-Gr1 (CTX-MGr1_Fout2, 5¢-
GACTATTCATGTTGTTGTTAWTTCG; CTX-MGr1-Rout,
5¢-TTCCCCATTCCGTTTCCG [PCR and sequencing] and
CTX-MGr1-FinSeq, 5¢-CGCGTGATACCACTTCAC; CTX-
MGr1_RinSeq, 5¢-CCGACTGCCGCTCTAATT [sequenc-
ing], [designed from consensus sequences obtained from the
GenBank accession no. X92506, GQ274934, AY458016,
JQ343850]). For cba (cba-F, 5¢-AAGGCAGTGGAGTTTC
TCCG; cba-R, 5¢-AACGTTTTACCCAACGCAGC [Gen-
Bank accession no. NC_014382.1]), cif (cif-F, 5¢-CCATGCA
ACACACTTCAGCC; cif-R, 5¢-GCTGCTCGAGCGATAG
2 VOGT ET AL.
TGTC [GenBank accession no. AY128544.]), ireA (ireA-F,
5¢-CACTGGGTAGCAGCATGGAA; ireA-R, 5¢-TGAAGG
AGCCCGAAATGCTT [GenBank accession no. NC_
008563.1]), iroN (iroN-F, 5¢-AGCCGGAAAGTAGCGATG
AG; iroN-R, 5¢-GACTTTGTCCCCAGTCCCAG [GenBank
accession no. NC_011964.1]), and nleA (nleA-F. 5¢-ACCGAG
CCAAAAGACCCAAT; nleA-R, 5¢-CTTGCCCAACCATTG
CACC [GenBank accession no. NC_013008]). blaCMY genes
were amplified using previously described primers and se-
quenced with both the recommended primers,36 and using an
additional internal sequencing primer blaCMY-2_IntF1 5¢-
ACAACTTGACGCCGAAGC (GenBank accession no.
X91840)].
Amino acid substitutions in the quinolone resistance-
determining region of GyrA and ParC were detected as
described previously.7
PCR was performed using 5·HOT FIREPol Master Mix
Ready to Load (Solis BioDyne) under the following condi-
tions: initialization for 15min at 94C followed by 35 cycles
of amplification for 30 s at 94C, 30 s at 48–60C, and 1min
at 72C and a final elongation step at 72C for 5min. Selected
DNA amplicons were sequenced using Big Dye by the
Sanger method/chain termination method on an ABI Prism
3100 Genetic Analyzer (Applied Biosystems).
Genotyping and determination of phylogenetic group
Genotyping was performed by Multi Locus Sequence
Typing (MLST) using the method described by Wirth et al.
200656 and the sequence types (ST) were obtained with the
database provided by the University College Cork, Ireland
(http://mlst.ucc.ie/mlst/dbs/Ecoli). Plasmid incompatibility
(Inc) groups were determined using a multiplex PCR-based
replicon typing kit (PBRT kit MBK0038; Diatheva). Plasmids
were extracted using the alkaline lysis method, including the
phenol/chloroform purification step,47 and transformed into
E. coli TOP10 cells by electroporation (Invitrogen). The
transformants were selected on Mueller Hinton II agar con-
taining either 70mg/L of ampicillin or 2mg/L cefotaxime and
confirmed for the presence of blaCTX-M and blaCMY genes by
colony PCR. Inc groups of the transformed plasmids were
confirmed by PCR using specific primers described previ-
ously.8 Plasmids of the IncI1 group were further typed by
Plasmid MLST28 and the STs were obtained using the
PubMLST database (http://pubmlst.org/plasmid).
The phylogenetic groups of the isolates were obtained
using the triplex PCR method previously described.10 The
minimum spanning tree was constructed with Bionumerics
7.1 (Applied Maths).
Statistical analysis
Prevalence was calculated using R version 3.0.1 (The R
foundation for Statistical Computing, www.r-project.org).
Results
Prevalence
The prevalences of 3GC-R-Ec were 73.3% (confidence
interval [CI] 95%: 62–83%, n = 55/75) in chicken, 2% (CI
95%: 0–10%, n = 1/50) in beef, and 0% (CI 95%: 0–7.1%,
n = 0/50) in pork and veal retail meat. No carbapenem-
resistant E. coli (Fig. 1) were detected, even for those col-
onies growing on Brilliance CRE agar. However, colonies
containing CMY-2 (n= 8/9) and CTX-M-1 (n = 1/9) were
found growing on this agar, as already reported.12
3GC-R-Ec isolates
The only 3GC-R-Ec isolated from beef retail meat belonged
to ST453, phylogenetic group B1, and it contained a blaCTX-M-1
gene as well as genes conferring resistance to sulfamethoxazole
(sul2), tetracycline [tet(B)], and trimethoprim (dfrA17) and a
class 1 integrase as well as an IncI1 plasmid (Table 1).
FIG. 1. Percentage of resistance and resistance determinants among isolates from chicken meat. 3GC, third-generation
cephalosporins; CHL, chloramphenicol; CIP, ciprofloxacin; COL, colistin; GEN, gentamicin; IMI, imipenem; KAN,
kanamycin; MER, meropenem; NAL, nalidixic acid; SMX, sulfamethoxazole; TET, tetracycline; TMP, trimethoprim;
CMY, pAmpC b-lactamase; CTX-M-1, ESBL; SHV-12, ESBL; DfrA, dihydrofolate reductase for trimethoprim resistance;
Sul, dihydropteroate synthetase for sulfonamide resistance; Tet, tetracycline efflux.
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The 68 isolates from chicken retail meat (nine samples
contained two and two samples contained three different STs)
carried blaCTX-M-1 (79.4%), blaCMY-2 (17.6%), blaCMY-4
(1.5%), or blaSHV-12 (1.5%) and were frequently associated
with additional resistance genes, such as sul sulfonamide re-
sistance genes, dfrA trimethoprim resistance genes, and tet
tetracycline resistance genes (Fig. 1). Multidrug resistance
was present in 61.8% of the isolates, which were resistant to
three to six different antibiotics. The most frequent resistances
were to third-generation cephalosporins, sulfamethoxazole,
nalidixic acid, trimethoprim, and tetracycline (Fig. 1 and
Table 1). One strain exhibited resistance to ciprofloxacin,
which was associated to amino acid substitutions Ser83Leu,
Asp87Asn in GyrA, and Ser80Arg in ParC.
The isolates from poultry belonged to 18 different STs,
with the most frequent being ST1304 (n= 15), ST38 (n= 12),
ST93 (n= 9), ST770 (n= 6), ST1158 (n= 6), ST371 (n= 5),
and ST155 (n= 4) (Table 1). Isolates belonging to the same
ST also belonged to the same phylogenetic group except for
ST93 isolates that formed two different groups (Table 1). The
blaSHV-12 and blaCMY-4 genes were each only present in one
ST, and blaCMY-2 genes were present in two STs, whereas
blaCTX-M-1 was widespread in 15 different STs (Fig. 2). Iso-
lates belonging to the same ST also contained the same re-
sistance profiles and the same antibiotic resistance genes.
Most of them also contained the same plasmid replicon types.
The predominant Inc groups were IncI1 (91.2%), IncFIB
(83.8%), IncFII (80.9%), IncB/O (45.6%), IncK (36.8%),
IncY (11.8%), and IncI2 (8.8%), whereas IncFIA, IncHI1,
IncP, and IncX1 were only detected once (1.5%) (Table 1).
Plasmids belonging to IncI1 (98.1%), IncFIB (85.2%), and
IncFII (81.5%) were the most frequent in isolates harbor-
ing blaCTX-M-1, and the Inc groups IncB/O (100%), IncFIB
(100%), IncFII (100%), IncK (100%), and IncI1 (83.3%)
were most common in blaCMY-2 carriers. Analysis of the
blaCTX-M-1-positive plasmids transformed from six genet-
ically diverse strains (ST93, ST155, ST1304, ST2248,
ST2307, and ST4007) as well as four genetically related
strains (all of ST1304) into E. coli Top10 cells revealed
that they all belonged to the IncI1 group and were of
plasmid sequence type 3 (pST3). Similarly, the plasmids of
three strains containing blaCMY-2 (two strains belonging to
ST38 and one to ST1564) as well as of one strain con-
taining blaCMY-4 (ST38) all belonged to the IncB/O group
as determined by PCR (Table 1 and Fig. 2).
Virulence factors
A total of 12 different virulence factor genes could be
identified from the isolates (Table 1). The APEC-associated
iroN and iss genes were found in 59.4% and 76.8% of the
isolates, respectively; in 59.4% of the isolates, they were
detected together. Other APEC-associated virulence genes,
including tsh, astA, and hylE, were found less frequently
(<4.3%). The lpfA (long polar fimbriae) gene was only de-
tected in one predominant clonal lineage ST1304 (100%).
One strain belonging to ST752 contained enteropathogenic
E. coli (EPEC)/EHEC-associated virulence factor genes cif,
espB, nleA, and tir additionally to iss, iroN, and tsh. The
isolates belonged to different phylogenetic groups; A: 18.8%,
B1: 33.3%, B2: 2.9%, D: 27.5%, E: 15.9%, and F: 1.4%
(Table 1).
Discussion
A very high prevalence (i.e., 73.3%) of 3GC-R-Ec was
found at retail in poultry meat from indigenous animal
FIG. 2. Minimum spanning tree of the 3GC-R-Ec isolates from chicken retail meat. Each circle represents one sequence
type (ST), and the size of the circle reflects the number of isolates belonging to a particular ST. Plasmid sequence type 3
(pST3) and incompatibility groups (IncI1 and IncB/O) are indicated if detected within an ST. Lines between the circles
indicate the relationships between the different STs. Green: STs found on samples from MPPA, Red: STs found on samples
from MPPB. Blue: blaCTX-M-1-containing isolates. Yellow: blaCMY-2- and blaCMY-4-containing isolates. Orange: blaSHV-12-
containing isolate. 3GC-R, third-generation cephalosporin resistant; MPP, meat-packing plant.
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production in Switzerland, whereas beef (2%), pork (0%),
and veal (0%) meats were less or not contaminated. The
same observation has already been made for meat destined
for hospital meals in Switzerland as well as in other coun-
tries.4,5,17,52 However, the analysis of meat packed in two
different MPPs and purchased at different time points indi-
cates that contamination is not a sporadic event, but likely
occurs during slaughter and meat processing (Table 2). In-
deed, the prevalence of 3GC-R-Ec in Swiss poultry meat is
higher as that observed in Swiss broiler herds (38%).6 The
high rate of clonality for samples from the same slaughter-
house found here underlines the possible spread and persis-
tence of bacteria in meat packing plants, whereas 3GC-R-Ec
containing CTX-M-1 from broilers are very diverse.21
Swiss meat contained CTX-M-1-, CMY-2-, and SHV-12-
possessing E. coli, which are also the most frequent 3GC-R-
Ec detected in animals in Switzerland and Europe.49 The
E. coli also belong to the ST commonly detected among
poultry isolates (ST10, ST48, ST57, ST69, ST93, ST155,
ST770, and ST1304) around Europe and in Switzerland49,50
(personal communication). Similarly to other studies, iso-
lates from poultry meat harboring blaCTX-M-1 were mainly
associated with the presence of IncI1 plasmids, and those
containing blaSHV-12 with IncFIB, IncFII, and IncI1 plas-
mids.2,18,20,28,49,54 The blaCMY-2 and blaCMY-4 genes were
associated with IncB/O plasmids, which is uncommon. In
fact, the association of blaCMY-2 with IncB/O plasmids has
only been recently reported in E. coli isolates from broilers
in Japan,30 while blaCMY-2 has mainly been associated with
IncK and IncF1 plasmids in other European countries.2,20,54
This suggests that a particular CMY-2 plasmid has been
selected and is circulating among E.coli of the Swiss poultry
meat production. Of note, all the CTX-M-1-expressing
plasmids analyzed belonged to IncI1/pST3, an epidemic
plasmid propagating in Enterobacteriaceae from different
human and animal sources, including poultry in several
European countries (plasmid MLST isolate database [http://
pubmlst.org/databases]).2,15,28,29 In our study, the blaCTX-M-1-
containing IncI1/pST3 plasmid was detected in both geneti-
cally related and genetically diverse E. coli strains, further
emphasizing the interstrain exchange of this promiscuous
plasmid in the poultry meat production.
The detection of chicken-associated toxins in the 3GC-R-
Ec emphasizes that the isolates originated from poultry.
Indeed, the predominant virulence factors iroN and iss as
well as tsh have been associated with plasmids in APEC,
principally ColV and ColBM from the IncFIB group,33 and
also with plasmids of the IncB/O, IncFII, IncI1, and IncP
groups.35 Such Inc groups were also frequent in isolates
from Swiss poultry meat. The iroN und iss genes are lo-
cated on a conserved region, whereas tsh is on a more
variable portion of the putative virulence region of the
plasmid and may be absent, explaining the lower frequency
of tsh found here.34 This large virulence plasmid (ColV)
has also been found in other ExPEC but to a lesser extent.19
The role of such virulence factors has not yet been fully
understood in human infections.23 However, two isolates
(ST752 and ST1304) harbor the virulence factor genes (cif,
espB, lpfA, nleA, and tir) that have been associated with
human EHEC/EPEC (Table 1).3 Additionally, chicken
meat was found to contain 3GC-R-Ec, which belonged to
the same STs and contained the same cephalosporinase
genes (ST69/CMY-2, ST10/CTX-M-1, and ST453/CTX-
M-1) as some of those causing infections in humans in
Switzerland,48 suggesting a possible transmission of 3GC-
R-Ec from retail meat to humans. Such a phenomenon has
already been observed in the Netherlands, where patients,
retail chicken meat, and poultry were shown to share the
same ESBL genes, plasmids, and strains.22
Nevertheless, the pandemic strain ST131 carrying
blaCTX-M-15, which is responsible for most ESBL-producing
human infections in Europe46,49 and in Switzerland,48 has not
yet been found in meat produced in Switzerland,21,49 al-
though it has been detected in a chicken farm in Spain.13
Even if no isolate with the typical characteristics of the
most prevalent human ST131/CTX-M-15 was detected during
this study, a worrisome high rate of 3GC-R-Ec was detected
in retail chicken meat originating from indigenous broiler
production. Of further concern, this observation included
isolates with human infection-associated STs, as well as those
containing genes contributing to pathogenicity on humans,
and the presence of an epidemic blaCTX-M-1-containing plas-
mid known to be widespread in Enterobacteriaceae from both
animal and human origin.
The presence of such multidrug-resistant bacteria with
pathogenic potential in meat should be avoided. This goal
could be achieved by adopting the Hazard Analysis and
Critical Control Point and continuously monitoring concepts
along the entire meat production chain up to retail, to track
back sources of microbial contamination, and by im-
plementing stricter hygiene concepts to stop the cascade of
multidrug-resistant bacteria before they reach consumers.
Table 2. Distribution of Sequence Types from Chicken Meat Over
the Sampling Weeks Among the Meat-Packing Plants A and B
Sampling week Sampling week
ST (n) W1 (n) W5 (n) W9 (n) ST (n) W1 (n) W5 (n) W9 (n)
ST1304 (15) A (1) A (2), B (11) A (1) ST57 (1) A (1)
ST38 (12) A (6) A (6) ST69 (1) B (1)
ST93 (9) B (1) A (8) ST752 (1) A (1)
ST770 (6) A (1), B (5) ST1056 (1) A (1)
ST1158 (6) A (6) ST1564 (1) A (1)
ST371 (5) A (5) ST1850 (1) A (1)
ST155 (4) B (1) A (1), B (1) A (1) ST2248 (1) A (1)
ST10 (1) B (1) ST2307 (1) A (1)
ST48 (1) B (1) ST4007 (1) B (1)
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